SU858563A3 - Method of preparing quinazoline derivatives or their salts - Google Patents
Method of preparing quinazoline derivatives or their salts Download PDFInfo
- Publication number
- SU858563A3 SU858563A3 SU762386166A SU2386166A SU858563A3 SU 858563 A3 SU858563 A3 SU 858563A3 SU 762386166 A SU762386166 A SU 762386166A SU 2386166 A SU2386166 A SU 2386166A SU 858563 A3 SU858563 A3 SU 858563A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- group
- formula
- salts
- quinazoline derivatives
- groups
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
- C07D239/94—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Procedimiento para preparar derivados de quinazolina, de fórmula: **(Fórmula)** en la que (i) R1 es un átomo de hidrógeno o un grupo alquilo inferior; (R2)n representa de 1 a 3 sustituyentes opcionales, siendo cada R2 un átomo de hidrógeno o un grupo hidroxi o alcoxi inferior y siendo n de 1 a 3, o constituyendo dos cualquiera de las mitades R2 un grupo metilendioxi o etilendioxi unido a posiciones adyacentes del anillo A; (ii) X representa - (CH2)p-en donde p es 1 a 3; (iii) y está unido a la posición 3 ó 4 del anillo C y representa un grupo de fórmula -Z-CO-NHR6 ó -Z-CS-NHR6.Process for preparing quinazoline derivatives, of the formula: (Formula) ** wherein (i) R 1 is a hydrogen atom or a lower alkyl group; (R2) n represents from 1 to 3 optional substituents, each R2 being a hydrogen atom or a hydroxy or lower alkoxy group and n being from 1 to 3, or any two of the R2 halves constituting a methylenedioxy or ethylenedioxy group attached to positions adjacent to ring A; (ii) X represents - (CH2) p- wherein p is 1 to 3; (iii) and is attached to the 3 or 4 position of the C ring and represents a group of formula -Z-CO-NHR6 or -Z-CS-NHR6.
Description
(54) СПОСОБ ПОЛУЧЕНИЯ ПРОИЗВОДНЫХ ХИНАЗОЛИНА Изобретение относитс к способу получени новых производных хинаэоли на формулы где У - NHCONR R,z, NHC S NR R, или CHaCONR R группы, где R низша алкильна группа, Су- оксиалкильна группа , алкил, алкенил или алкинил , замещенные пиридилом. RJ,- водород, и R совме но с атомом азота, к которо му они присоединены, образу ют пиперидиновое кольцо, X - группа СН2.-СН или, когда V-CHACON ; группа, то X - группа - СН С. , или их солей, которые обладают биологической активнос тью. Известен способ взаимодействи изоцианатов с аминами ij. Цель изобретени - способ получе ни новых производных хиназолина, которые могут найти применение в ка ИЛИ ИХ СОЛЕЙ честве биологически активных соединений . Поставленна цель достигаетс способом получени соединений формулы 1, заключающемс в том, что хинлэолин формулы группьа NCO, NCS или CftjCOQ, причем Q представл ет собой легко отщепл емую группу, такую как хлор, бром или О -о-а. X - , или когда Z пред ставл ет собой CH,.COQ, то X - , подвергают взаимодействию с соедине ннем формулы NH, где ft-ji имеют указанные значени в среде инертного растворител при комнатной температуре и вьадел ют целевой продукт в свободном виде ил в виде соли. Фармацевтически применимые соли присоединени кислот соединений фор мулы 1 представл ют собой такие сое динени , которые получают из кислот содержащие фармацевтически применимые анионы, например, такие как гид рохлорид, гидробромид, гидрооксид, сульфат или бисульфат, фосфат или .кислый фосфат, ацетат, малеат, фум рат, оксалат, лактат, гартрат, цитрат , глюконат, сахарат и п-голуилсульфонат . Пример. 1/ДССД и N-гидроксисукцннамид 2(СНз)СН2) CH,COf{}iiCHg),C CH-COM),CHj4- (4-карбоксиметил)-1,2, 3,6-тет рагидролирид-1-ил -6,7-диметоксихимазолин гидрохлорид (0,92 г), полученный гидролизом эфира в сухом хлороформе (20 мл), содержащий триэтиламин (0,3 г), перемешивают до полного завершени реакции. Дициклогексил карбодиимид (0,63 г и N-гидроксисукцинимид (0,35 г) добавл ют с последующим сто нием в течение ночи, в результате чего осаждаетс более твердое вещество н-бутиламин (0,22 г), добавл ют к смеси и снова оставл ют сто ть 5 ч, после чего раствор фильтруют, промывают водой, и органическую фазу выпаривают в вакууме досуха. Остаток обрабатывают ацетонитрилом, фильтру|от, и Фильтоат обрабатывают эфирным раствором НС1 до образовани кисло ,ты. Осадившийс гидрохлорид 4-.И-Н-бутилкарбамоилметил )-1,2,3,6-тетрадидропирид-1-ил -6,7-диметоксихин-; азолин перекристаллизовывают из эта ,нола. Выход 340 мг при 1 . в виде полугидрата., Вычислено, %: С 58,65, Н 7,0, N 13,0. C2i%gN 03-l/2 НгО Найдено, %: С , Н 6,7; N 12,9. Примеры 2-7. Получение производных соединений формулы Результаты представлены -в таблице.(54) METHOD FOR PRODUCING HINAZOLINE DERIVATIVES The invention relates to a method for producing new quinae derivatives of the formulas where Y is NHCONR R, z, NHC S NR R, or CHaCONR R groups where R is a lower alkyl group, a hydroxyalkyl group, an alkyl, alkenyl or quinil, substituted pyridyl. RJ, is hydrogen, and R together with the nitrogen atom to which they are attached form a piperidine ring, X is the group CH2. —CH or when V is CHACON; the group, then the X — group — CH. S., or their salts, which possess biological activity. There is a method of reacting isocyanates with amines ij. The purpose of the invention is a method for the preparation of new quinazoline derivatives, which can be used in OR THEIR SALT as biologically active compounds. The objective is achieved by a process for the preparation of compounds of formula 1, namely, quinoline of the formula NCO, NCS or CftjCOQ, with Q being an easily removable group such as chlorine, bromine or O-o-a. X -, or when Z is CH, .COQ, then X - is reacted with a compound of formula NH, where ft-ji have the specified values in an inert solvent at room temperature and implant the desired product in free form. in the form of salt. The pharmaceutically applicable acid addition salts of the compounds of Formula 1 are those which are derived from acids containing pharmaceutically applicable anions, such as hydrochloride, hydrobromide, hydroxide, sulfate or bisulfate, phosphate or phosphate, acetate, maleate, fum rat, oxalate, lactate, gartrat, citrate, gluconate, saharat and p-goluylsulfonat. Example. 1 / DSSD and N-hydroxysuccinnamide 2 (CH3) CH2) CH, COf {} iiCHg), C CH-COM), CHj4- (4-carboxymethyl) -1,2, 3,6-tetrahydrolirid-1-yl - 6,7-dimethoxychimazoline hydrochloride (0.92 g), obtained by hydrolysis of ether in dry chloroform (20 ml) containing triethylamine (0.3 g), is stirred until the reaction is complete. Dicyclohexyl carbodiimide (0.63 g and N-hydroxysuccinimide (0.35 g) is added, followed by standing overnight, resulting in more solid n-butylamine (0.22 g) precipitating, added to the mixture and again left to stand for 5 hours, then the solution is filtered, washed with water, and the organic phase is evaporated in vacuo to dryness. The residue is treated with acetonitrile, filtered, and the Filtoate is treated with ethereal HCl to form an acidic acid. The precipitated hydrochloride 4-I. N-butylcarbamoylmethyl) -1,2,3,6-tetradidropyrid-1-yl-6,7-dimethoxyquin-; Azoline is recrystallized from eta, nola. Exit 340 mg at 1. as a hemihydrate., Calculated,%: C 58.65, H 7.0, N 13.0. C2i% gN 03-l / 2 HgO Found;%: C, H 6.7; N 12.9. Examples 2-7. Obtaining derivatives of compounds of the formula The results are presented in the table.
2/ NHCONH( (СНз) 4-Положег-2 / NHCONH ((CH3) 4-Put-
NHCON NHCON
То жеДигидрохло- 136-201 53,39The same Dihydrochlo- 136-201 53.39
(53,87(53.87
-NHCONH(CH.2) ОН-NHCONH (CH.2) OH
Свободное основание NHCONH(CH,)2 .Свободное -пиридил основаниеFree base NHCONH (CH,) 2. Free-pyridyl base
Свободное Free
NHCONH-CHj CHsCHj, основаниеNHCONH-CHj CHsCHj, base
6,56 13, 6,68 13,31)6.56 13, 6.68 13.31)
6,61 6.61
14,8214.82
15,54) 6,4315.54) 6.43
131-145 59,54 7,24 17,36 (58,96 7,84 16,97)131-145 59.54 7.24 17.36 (58.96 7.84 16.97)
211-214 61,446,78 18,85211-214 61,446,78 18,85
(61,iJ 6,81 18,85) Монотертрат,122-135 53,62 ( 53,39 199-201 63,29 6,47 19,25 (63,26 6,37 18,96)(61, iJ 6.81 18.85) Monotertrate, 122-135 53.62 (53.39 199-201 63.29 6.47 19.25 (63.26 6.37 18.96)
NHCONHCH C S СНNHCONHCH C S CH
МоногидратMonohydrate
197-190 58,90 (59,35197-190 58.90 (59.35
Claims (1)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB3280574 | 1974-07-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
SU858563A3 true SU858563A3 (en) | 1981-08-23 |
Family
ID=10344259
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU7502162232A SU578874A3 (en) | 1974-07-25 | 1975-07-25 | Method of preparing quinozaline derivatives or their salts |
SU762386166A SU858563A3 (en) | 1974-07-25 | 1976-08-02 | Method of preparing quinazoline derivatives or their salts |
SU762388319A SU613723A3 (en) | 1974-07-25 | 1976-08-10 | Method of obtaining quinazoline derivatives or salts thereof |
SU762388320A SU625606A3 (en) | 1974-07-25 | 1976-08-10 | Method of producing quinazoline or their salts |
SU762388318A SU634671A3 (en) | 1974-07-25 | 1976-08-10 | Method of obtaining quinazoline derivatives or salts thereof |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU7502162232A SU578874A3 (en) | 1974-07-25 | 1975-07-25 | Method of preparing quinozaline derivatives or their salts |
Family Applications After (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU762388319A SU613723A3 (en) | 1974-07-25 | 1976-08-10 | Method of obtaining quinazoline derivatives or salts thereof |
SU762388320A SU625606A3 (en) | 1974-07-25 | 1976-08-10 | Method of producing quinazoline or their salts |
SU762388318A SU634671A3 (en) | 1974-07-25 | 1976-08-10 | Method of obtaining quinazoline derivatives or salts thereof |
Country Status (7)
Country | Link |
---|---|
AT (1) | AT344178B (en) |
BE (1) | BE831654A (en) |
CS (1) | CS192549B2 (en) |
ES (4) | ES439690A1 (en) |
HU (1) | HU174961B (en) |
PL (6) | PL103789B1 (en) |
SU (5) | SU578874A3 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070004763A1 (en) * | 2005-06-10 | 2007-01-04 | Nand Baindur | Aminoquinoline and aminoquinazoline kinase modulators |
-
1975
- 1975-07-08 AT AT525275A patent/AT344178B/en active
- 1975-07-18 HU HU75PI483A patent/HU174961B/en unknown
- 1975-07-18 PL PL1975193420A patent/PL103789B1/en unknown
- 1975-07-18 PL PL1975182162A patent/PL99427B1/en unknown
- 1975-07-18 PL PL1975193423A patent/PL103797B1/en unknown
- 1975-07-18 PL PL1975193419A patent/PL103798B1/en unknown
- 1975-07-18 PL PL1975193422A patent/PL104615B1/en unknown
- 1975-07-18 PL PL1975193421A patent/PL103791B1/en not_active IP Right Cessation
- 1975-07-21 CS CS755147A patent/CS192549B2/en unknown
- 1975-07-23 BE BE158540A patent/BE831654A/en not_active IP Right Cessation
- 1975-07-24 ES ES439690A patent/ES439690A1/en not_active Expired
- 1975-07-25 SU SU7502162232A patent/SU578874A3/en active
-
1976
- 1976-08-02 SU SU762386166A patent/SU858563A3/en active
- 1976-08-10 SU SU762388319A patent/SU613723A3/en active
- 1976-08-10 SU SU762388320A patent/SU625606A3/en active
- 1976-08-10 SU SU762388318A patent/SU634671A3/en active
-
1977
- 1977-02-16 ES ES455986A patent/ES455986A1/en not_active Expired
- 1977-02-16 ES ES455984A patent/ES455984A1/en not_active Expired
- 1977-02-16 ES ES455985A patent/ES455985A1/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
ES455985A1 (en) | 1978-06-16 |
SU578874A3 (en) | 1977-10-30 |
PL99427B1 (en) | 1978-07-31 |
ES455984A1 (en) | 1978-06-01 |
PL193423A1 (en) | 1978-04-24 |
AT344178B (en) | 1978-07-10 |
PL103797B1 (en) | 1979-07-31 |
SU634671A3 (en) | 1978-11-25 |
PL103791B1 (en) | 1979-07-31 |
PL103798B1 (en) | 1979-07-31 |
PL193421A1 (en) | 1978-04-24 |
ES439690A1 (en) | 1977-07-01 |
PL193422A1 (en) | 1978-06-05 |
HU174961B (en) | 1980-04-28 |
ATA525275A (en) | 1977-11-15 |
SU625606A3 (en) | 1978-09-25 |
SU613723A3 (en) | 1978-06-30 |
PL103789B1 (en) | 1979-07-31 |
CS192549B2 (en) | 1979-08-31 |
BE831654A (en) | 1976-01-23 |
PL193420A1 (en) | 1978-04-24 |
PL193419A1 (en) | 1978-04-24 |
ES455986A1 (en) | 1978-06-01 |
PL104615B1 (en) | 1979-08-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US2627491A (en) | Penicillin salts of substituted alkylene diamines | |
SU1428199A3 (en) | Versions of method of producing derivatives of 2,2,3-iminobisethanol or acid-additive salts thereof,or stereochemical isomeric forms thereof | |
US4315007A (en) | 4-Amino-6,7-dimethoxyquinazol-2-yl alkylenediamines | |
US3972932A (en) | Novel 2,6-disubstituted phenyl-aminoguanidine compounds | |
SU858563A3 (en) | Method of preparing quinazoline derivatives or their salts | |
US5155116A (en) | Medicinal oxazolopyridine compounds | |
EP0179408B1 (en) | Amidoalkyl melamines and aminoalkyl melamines, and process for their preparation | |
DE3122784A1 (en) | "N (ARROW HIGH) 6 (ARROW HIGH) SUBSTITUTED ADENOSINES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME" | |
CA1118445A (en) | N,n'-[bis(n-cyanoguanyl)] crystamine derivatives | |
EP0033789B1 (en) | 2-alpha-methyl-dopaminimino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, its salts, and a process for preparation thereof | |
US4120858A (en) | 14-Substituted vincanes | |
IL25315A (en) | O-(2-guanidino-ethyl)-oximes | |
DE2114884A1 (en) | Basically substituted derivatives of 1 (2H) -phthalazinone | |
US3929803A (en) | Aryl carboxylic acids | |
US2328594A (en) | Compo und | |
SU493067A3 (en) | The method of obtaining phenylimidazolidinone | |
JPH0625191B2 (en) | 1- [2- (phenylmethyl) phenylphenylperazine compound, its production method and pharmaceutical composition | |
US4290971A (en) | Method of preparing 2-(phenylamino)-imidazolines-(2) | |
CS207661B2 (en) | Method of making the 1-phenylethanolamin derivatives | |
CA1041098A (en) | 1-(3-(naphthyl-1-yl-oxy)-propyl)-piperazine derivatives | |
GB2023574A (en) | N-cyano-azomethine derivatives | |
US3278542A (en) | ||
SU694497A1 (en) | 1 -adamantylammonium beta -chloroethyloxaminate exhibiting adrenoblocking activity | |
US3252976A (en) | Process for making 2-secondary and tertiary amino-1-phenyl-ethane thiols | |
IL34882A (en) | Nitrofuryl-aminoalkoxy-pyrimidine |